Trials / Sponsors / Valent Technologies, LLC
Valent Technologies, LLC
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Sol Solid Tumors, Neuroblastoma, Rhabdomyosarcoma | Phase 1 | 2021-10-25 |